QuickView for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=468B4BFDEE6357D96E60304308247E73;jsessionid=8ABAD8E57969277BE736476461A92080;jsessionid=79B972D9795F53A5DEECDFF0703F486C;jsessionid=904E7AD29F91E3321AF6966AB068BBDD;jsessionid=AD55681A9B5C05A84D538EF43723F5E3 (gene)

1. Treatment with the selective PDE4B inhibitor A-33 or PDE4D inhibitor zatolmilast prevents sleep depr…
2. Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic …
3. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains.
4. Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains.
5. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.

There were no clinical trials for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=468B4BFDEE6357D96E60304308247E73;jsessionid=8ABAD8E57969277BE736476461A92080;jsessionid=79B972D9795F53A5DEECDFF0703F486C;jsessionid=904E7AD29F91E3321AF6966AB068BBDD;jsessionid=AD55681A9B5C05A84D538EF43723F5E3